S-Equol: a novel therapeutic for HIV-1-associated gastrointestinal dysbiosis.
Saved in:
| Title: | S-Equol: a novel therapeutic for HIV-1-associated gastrointestinal dysbiosis. |
|---|---|
| Authors: | Rodriguez MT; Cognitive and Neural Science Program, Department of Psychology, Barnwell College, University of South Carolina, Columbia, SC, USA., Olmstead SJ; Cognitive and Neural Science Program, Department of Psychology, Barnwell College, University of South Carolina, Columbia, SC, USA., McLaurin KA; Cognitive and Neural Science Program, Department of Psychology, Barnwell College, University of South Carolina, Columbia, SC, USA., Mactutus CF; Cognitive and Neural Science Program, Department of Psychology, Barnwell College, University of South Carolina, Columbia, SC, USA., Booze RM; Cognitive and Neural Science Program, Department of Psychology, Barnwell College, University of South Carolina, Columbia, SC, USA. |
| Source: | NeuroImmune pharmacology and therapeutics [NeuroImmune Pharm Ther] 2025 Dec 25; Vol. 4 (4), pp. 325-337. Date of Electronic Publication: 2025 Dec 25 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Walter de Gruyter GmbH Country of Publication: Germany NLM ID: 9918418388006676 Publication Model: eCollection Cited Medium: Internet ISSN: 2750-6665 (Electronic) Linking ISSN: 27506665 NLM ISO Abbreviation: NeuroImmune Pharm Ther Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2750-6665 |
|---|---|
| DOI: | 10.1515/nipt-2024-0024 |
